http://www.croasia.net en-US Wed, 19 Jun 2013 11:51:13 -0700 Copyright(C) http://www.croasia.net Powered By SwiftSite version 1.2 http://www.croasia.net/news/wuxi_expands_antibody_discovery_partnership_with_transgenic_animal_developer.html Press Release 2013-03-02 WuXi PharmaTech has expanded its partnership with Open Monoclonal Technology (OMT) to use its transgenic rats and mice in China and other Asian countries ... http://www.croasia.net/news/axis_clinicals_announces_dr_yati_chugh_as_ceo.html Abhijit Chaudhari 2013-01-25 Dr. Chugh assumes the responsibility for overall activities of AXIS Clinicals Group companies with presence in India, Thailand and Mexico ... http://www.croasia.net/news/wuxi_pharmatech_and_pra_form_joint_venture_to_offer_clinical_research_services_for_chinese_market.html Press Release 2012-12-18 The joint venture will provide services including clinical trial monitoring, project management, regulatory strategy and submissions, data management ... http://www.croasia.net/news/axis_clinicals_announces_successful_completion_of_fda_audit.html Press Release 2012-07-30 AXIS Clinicals successful audits confirmed that the company's quality system was found to meet the requirements established by the US ... http://www.croasia.net/news/shangpharma_corporation_issues_statement_in_response_to_name_confusion.html Press Release 2012-05-29 The statement is to clarify potential market confusion between the name of the Company and Shanghai Pharmaceuticals Holdings Co., Ltd ... http://www.croasia.net/news/makrocare_opens_new_office_in_london_uk.html MakroCare 2012-05-17 The new London team will extend Regulatory and Safety leadership to MakroCare. This office, along with presence in Germany and Switzerland ... http://www.croasia.net/news/newbridge_pharmaceuticals_to_commercialize_ebernet_in_the_afmet_region.html Luqa Pharmaceuticals 2012-04-10 NewBridge Pharmaceuticals today announced that it has entered into an exclusive license and supply agreement to commercialize Ebernet in the AfMET region ... http://www.croasia.net/news/wuxi_pharmatech_acquires_abgent.html Press Release 2011-10-13 Abgent brings to WuXi new product lines of biological research reagents for drug discovery and basic research to expand its service offering to its existing customers ... http://www.croasia.net/news/shangpharma_subsidiary_and_jiangsu_hengrui_form_partnership.html Press Release 2011-09-15 Through the partnership, ChemPartner and Hengrui will initially collaborate on the development of novel therapeutic mAbs in a major therapeutic area ... http://www.croasia.net/news/pharmaron_forms_a_strategic_partnership_with_merck_serono.html 2011-09-14 The focus of this laboratory will be clinical bioanalysis and biomarker characterization, allowing for the identification of gene mutations among the Chinese population ... http://www.croasia.net/news/merck_and_bgi_establish_strategic_collaboration_on_genomic_rd.html 2011-09-13 Under the agreement scientists from Merck and BGI will work closely together to identify and characterize biomarkers with an emphasis on drug discovery ... http://www.croasia.net/news/wuxi_to_add_clinical_services_in_china.html Press Release 2011-08-16 WuXi is entering the Chinese clinical trial services sector to help international clients introduce products in the high-growth country, according to Outsourcing-Pharma ... http://www.croasia.net/news/inc_acquires_australian_cro_trident_clinical_research.html Press Release 2011-06-01 Under the terms of the agreement, Trident will become a wholly owned affiliate of INC Research and will operate as Trident Clinical Research, an INC Research company ... http://www.croasia.net/news/sgs_to_open_mumbai_facility.html Press Release 2011-05-31 This investment will establish a dedicated Life Science Services GMP laboratory, with the ability to provide a wide range of analytical development and quality control testing services ... http://www.croasia.net/news/big_pharma_scales_up_china_investment.html Global Trend 2011-05-03 China investment will continue throughout 2011 and beyond as big pharma seeks to establish a strong presence in the rapidly growing and lucrative market ... http://www.croasia.net/news/icon_continues_to_expand_in_asia-pacific_regions.html Press Release 2011-03-29 ICON has opened a new office in Shanghai, China, and is also relocating its Beijing operations to larger premises ... http://www.croasia.net/news/pharmaron_signs_supply_deal_with_isis_pharmaceuticals.html Press Release 2011-03-16 Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. with nucleoside phosphoramidites at quantities up to 100 kg ... http://www.croasia.net/news/shenogen_signs_up_shangpharma_to_help_develop_cancer_drug.html Press Release 2011-03-16 The deal involves ShangPharma helping develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment ... http://www.croasia.net/news/wuxi_on_the_right_track_with_24percent_growth_in_revenues.html News Release 2011-03-10 During 2010, WuXi's sales totaled $334.1 million. The company predicts it'll reach around $400 million in 2011, a steady progression from an enterprise ... http://www.croasia.net/news/covance_receives_aaalac_accreditation_in_shanghai_china.html Press Release 2011-03-08 Covance continues to invest in China to offer its clients a growing range of preclinical safety assessment services to help pharmaceutical and biotechnology companies ...